StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Cellyan Biotechnology

Cellyan Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cellyan Biotechnology figures

See a number that looks wrong?